Faculty Information - SEKI Yasufumi

■ Published papers

1.	Original article	Clinical and radiological features of Rathke's cleft cysts with inflammatory change: Multivariable analysis of 262 surgically treated cases. 2026/03
2.	Case report	Drug-Induced Liver Injury Due to Potassium Iodide During Thyroid Storm 2026/03
3.	Case report	Pituitary dysfunction in trans-sellar encephalocele: a two-case report and a literature review. 2026/01
4.	Case report	Primary Adrenal Insufficiency Due to Recurrent Unilateral Adrenal Infarction in a Patient With Myelodysplastic Syndrome with Isolated del(5q) 2025/09/11
5.	Case report	TSH-binding Inhibiting Immunoglobulin-negative, Thyroid-stimulating Antibody-positive Amiodarone-induced Thyrotoxicosis 2025/09/01
6.	Original article	Reduced high-sensitivity C-reactive protein levels following weekly somapacitan in adults with growth hormone deficiency: a prospective pilot study 2025/07/29
7.	Case report	Subacute thyroiditis during anti-programmed cell death protein 1 antibody therapy: A case report 2025/05
8.	Case report	Hyponatremia due to preserved non-osmotic arginine vasopressin secretion in adipsic diabetes insipidus: a case report with review of literature. 2024/11
9.	Original article	Effect of GH Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels. 2023/11
10.	Original article	Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus. 2023/10
11.	Original article	Hyperuricemia and the Severity of Coronavirus Disease 2019 in Japan: A Retrospective Cohort Study - An Inseparable Relation with Hypertension and Chronic Kidney Disease 2023
12.	Original article	Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors 2022
13.	Original article	Comparison of the usefulness of the cardio-ankle vascular index and augmentation index as an index of arteriosclerosis in patients with essential hypertension. 2021/12
14.	Original article	Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves’ Disease: A Retrospective Cohort Study 2021/03/06
15.	Original article	Effect of Pretransplant Use of Calcimimetic on Parathyroid Function after Renal Transplantation. 2021
16.	Original article	Characteristics of NAFLD Based on Hypopituitarism. 2020/10
17.	Original article	Comparison of Shortened with Standard Saline Infusion Test for Primary Aldosteronism Diagnostics 2020/05/08
18.	Original article	Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism 2020/04/30
19.	Original article	Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma. 2020/02
20.	Case report	Primary aldosteronism in Klinefelter’s syndrome: two cases 2019/12
21.	Original article	Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism. 2019/12
22.	Case report	ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism. 2019/05
23.	Original article	Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level. 2018/06
24.	Original article	Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation. 2018/05
25.	Original article	Elevated (Pro)renin Receptor Expression Contributes to Maintaining Aerobic Metabolism in Growth Hormone Deficiency 2018/03
26.	Case report	Hormone-replacement Therapy for Hepatopulmonary Syndrome and NASH Associated with Hypopituitarism. 2018
27.	Original article	Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease. 2018
28.	Original article	Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism. 2017/12
29.	Original article	The relationships between the differences in central blood pressure and brachial blood pressure and other factors in patients with essential hypertension 2017
30.	Review article	Serum soluble (pro)renin receptor levels in patients with essential hypertension. 2014
31.	Original article	Add-on blockade of (pro)renin receptor in imidapril-treated diabetic SHRsp. 2010/06
Display 5 items
Display all(31)

■ Academic conference presentation

1.	A Case of Severe Heart Failure Due to Primary Aldosteronism with Improved Cardiac Function Following Adrenalectomy （Poster notice，General） 2026/10/18
2.	The Impact of Inpatient Educational Interventions on Patient Understanding and Behavioral Change in Hypertension Management （Poster notice，General） 2025/10/19
3.	Impact of surgical therapy and mineralocorticoid receptor antagonist therapy on left ventricular hypertrophy in patients with primary aldosteronism （Speech，General） 2025/10/18
4.	Acromegaly and Polycystic Kidney Disease in a Young Patient with Hypertension （Speech，General） 2025/10/17
5.	RAAS inhibition strategy for pregnant women: non-steroidal MR antagonists （Speech，Panelist at Symposium/Workshop (Appointed)） 2025/10/17
6.	Thyrotropin Level Predicts Postoperative Hypothyroidism in Patients with Nonfunctioning Pituitary Masses （Poster notice，General） 2025/07
7.	Primary adrenal insufficiency due to recurrent episodes of unilateral adrenal infarction （Poster notice，General） 2025/05
8.	Hypertension in middle-aged and menopausal women （Speech，Panelist at Symposium/Workshop (Appointed)） 2024/10/14
9.	Weekly Somapacitan Reduces Serum C-reactive Protein Levels in Adult Patients with Growth Hormone Deficiency （Poster notice，General） 2024/06/03
10.	Increased prevalence of uterine myoma in patients with idiopathic hyperaldosteronism （Poster notice，General） 2024/06/01
11.	A Case of Acromegaly Due to GH-secreting Tumor Mimicking ACTH Co-secretion （Poster notice，General） 2024/05
12.	Comparison of antihypertensive effects between eplerenone and esaxerenone, mineralocorticoid receptor antagonists, in patients with primary aldosteronism （Poster notice，General） 2024/05
13.	Romosozumab Therapy After Parathyroidectomy for Osteoporosis Caused by Primary Hyperparathyroidism: Two Case Reports （Poster notice，General） 2024/05
14.	A decrease in serum CRP levels after somapacitan therapy for adult growth hormone deficiency （Speech，General） 2024/02/16
15.	Growth hormone secretion and serum high-sensitivity C-reactive protein levels in adult patients with non-functioning pituitary tumors （Poster notice，General） 2023/06/17
16.	A negative association between growth hormone secretion and inflammation in adult patients with non-functioning pituitary mass （Poster notice，General） 2023/05/15
17.	Renoprotective Effect of Aliskiren Monotherapy in Hypertensive Patients with Obesity and Type 2 Diabetes Mellitus （Poster notice，General） 2022/10/15
18.	Increased Serum High-sensitivity C-reactive Protein in Growth Hormone-deficient Patients with Non-functioning Pituitary Tumors （Poster notice，General） 2021/03/20
19.	High-sensitivity C-reactive protein and growth hormone deficiency in patients with non-functioning pituitary tumors （Speech，General） 2021/02/19
20.	Effects of Body Mass Index and Estimated Glomerular Filtration Rate on Pituitary Function in Patients with Non-functioning Pituitary Tumor （Poster notice，General） 2019/05/19
21.	Effects of Obesity and Renal Function on Pituitary Function Tests in Patients with Nonfunctioning Pituitary Tumor （Poster notice，General） 2019/03/23
22.	Primary Aldosteronism in Klinefelter's Syndrome: Two Cases Report （Poster notice，General） 2018/09/22
23.	Primary Hyperparathyroidism in a Patient with Primary Aldosteronism （Poster notice，General） 2018/09/22
24.	Renoprotective Effect of Direct Renin Inhibitor Monotherapy in Hypertensive Patients with Type 2 Diabetes or Obesity （Speech，General） 2018/09/14
25.	Serum soluble (pro)renin receptor concentration is correlated with organ dysfunctions in patients with primary aldosteronism （Poster notice，General） 2018/09
26.	(Pro)renin Receptor Contributes to Maintaining Aerobic Metabolism in GH-deficient Adipose Tissue （Poster notice，General） 2018/03/18
27.	An old patient with acromegaly treated with consideration of past history and preventing frailty （Speech，General） 2018/02/09
28.	(Pro)renin receptor immunohistochemistry in human organs 2016/09
29.	A novel biomarker urinary soluble (pro)renin receptor excretion is associated with urineph 2016/09
30.	Evaluation of Insulin Sensitivity and Secretion in Primary Aldosteronism. (Pro)renin receptor immunohistochemistry in human organs. 2016/09
31.	Relationships between serum soluble (pro)renin receptor levels and endocrine or metabolic factors in patients with essential hypertension. 2015/09
32.	A Circulating Soluble (Pro)Renin Receptor Level and Its Changes with Growth Hormone replacement in Patients with Growth Hormone Deficiency 2014/06/21
33.	Associations between renal function and indices of renin-angiotensin system in patients with essential hypertension 2014/05
34.	Effects of the direct renin inhibitor on renin-angiotensin system in hypertensive patients with chronic kidney disease 2014/05
35.	Clinical implications of the difference in central blood pressure and brachial blood pressure in patients with essential hypertension 2014/04
36.	CVD therapy for unresectable pheochromocytoma （Poster notice，General） 2013/08
37.	Periodic ectopic Cushing's syndrome potentially evoked by glucocorticoid excess （Poster notice，General） 2013/06/16
38.	High-dose Cabergoline Treatment of Childhood- and Adolescence-onset Prolactinomas. （Speech，General） 2013/06
Display 5 items
Display all(38)

■ Qualifications & licenses

1.	2013/09	Board Certified Member of the Japanese Society of Internal Medicine
2.	2016/12	Fellow of the Japanese Society of Internal Medicine
3.	2017/04	Board Certified Endocrinologist (by JES)
4.	2018/07	Board Certified Member of the Japanese Thyroid Association
5.	2019/04	Board Certified Member of the Japanese Society of Hypertension
6.	2019/04	Board Certified Supervisor of the Japanese Society of Hypertension
7.	2019/05	Board Certified Member of the Japan Atherosclerosis Society
8.	2020/04	Board Certified Supervisor of Japan Atherosclerosis Society
9.	2022/04	Certified Endocrine Educator (by JES)
10.	2022/08	Board Certified Member of the Japanese Osteoporosis Society
11.	2023/10/01	Board Certified Specialist in Ultrasound-Guided Fine Needle Aspiration of the Thyroid (Japan Association of Breast and Thyroid Sonology)
12.	2023/12	Board Certified Member of the Japan Diabetes Society
Display 5 items
Display all(12)

■ Social activities

1.		Endocrine Journal誌査読
2.		Manuscript Reviewer, AACE Endocrinology and Diabetes
3.		Manuscript Reviewer, American Journal of Case Reports
4.		Manuscript Reviewer, BMC Endocrine Disorders
5.		Manuscript Reviewer, Heart and Vessels
6.		Manuscript Reviewer, Hypertension Research
7.		Manuscript Reviewer, Journal of Endocrinological Investigation
8.		Manuscript Reviewer, Tokyo Women's Medical University Journal
9.	2026	ENDO 2026査読
10.	2025	Secretary General of the 47th Annual Scientific Meeting of the Japanese Society of Hypertension
Display 5 items
Display all(10)

■ Research areas

Metabolism and endocrinology

■ Awards & honors

1.	2024/11	The 34th Clinical Endocrinology and Metabolism Update Outstanding Poster Award
2.	2019/11	The 47th Endocrinology and Metabolism Meeting Commentator Award
3.	2015/10	The 43rd Endocrinology and Metabolism Meeting Abstract Award
4.	2015/03	Endocrine Society ENDO 2015 Early Career Forum Travel Award
5.	2013/10	The 36th Annual Scientific Meeting of the Japanese Society of Hypertension Travel Grant
6.	2012/10	The 40th Endocrinology and Metabolism Meeting Abstract Award
Display 5 items
Display all(6)

■ Academic society memberships

1.

The Endocrine Society

■ Education

1.	2004/04～2010/03	School of Medicine, Keio University, Graduated, MD
2.	2012/04～2016/03	〔Doctoral course〕〔Doctorial Course〕, Graduate School of Medicine, Tokyo Women's Medical University, Completed, PhD

■ Academic & professional experience

1.	2010/04～2012/03	Japanse Red Cross Medical Center Resident
2.	2012/04～2017/03	Tokyo Women's Medical University Department of Endocrinology and Hypertension Fellow
3.	2017/04～2025/02	Tokyo Women's Medical University Department of Endocrinology and Hypertension Assistant Professor
4.	2017/10～2018/09	Tokyo Women's Medical University Diabetes Center
5.	2019/04～2020/03	Kanto Central Hospital of the Mutual Aid Association of Public School Teachers Department of Metabolism and Endocrinology Head Physician
6.	2025/03～2025/07	Tokyo Women's Medical University Division of Hormonal Medicine and Bioregulatory Science (Endocrinology and Hypertension), Department of Medicine Assistant Professor
7.	2025/08～	Tokyo Women's Medical University Division of Hormonal Medicine and Bioregulatory Science (Endocrinology and Hypertension), Department of Medicine Associate Professor
Display 5 items
Display all(7)

■ External Researcher ID

orcID

https://orcid.org/0000-0002-1950-7704